Trojer Patrick

Chief Scientific OfficerCONSTELLATION PHARMACEUTICALS INC (CNST) · full profile →Form 4 · filed Jul 19, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
10
0 non-derivative · 10 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 15, 2021Disposed to issuer(D)3K0
Jul 15, 2021Disposed to issuer(D)55K0
Jul 15, 2021Disposed to issuer(D)43K0
Jul 15, 2021Disposed to issuer(D)72K0
Jul 15, 2021Disposed to issuer(D)8500
Jul 15, 2021Disposed to issuer(D)78K0
Jul 15, 2021Disposed to issuer(D)17K0
Jul 15, 2021Disposed to issuer(D)40K0
Jul 15, 2021Disposed to issuer(D)33K0
Jul 15, 2021Disposed to issuer(D)23K0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001562180-21-004985) within minutes of acceptance. Every field above traces to the original document. Verify it directly: